See more : Comal S.p.A. (CML.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Medigene AG (MDG1.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medigene AG, a leading company in the Biotechnology industry within the Healthcare sector.
- Batero Gold Corp. (BELDF) Income Statement Analysis – Financial Results
- Gram Car Carriers ASA (G39.SG) Income Statement Analysis – Financial Results
- Konami Group Corporation (9766.T) Income Statement Analysis – Financial Results
- Osotspa Public Company Limited (OSOPF) Income Statement Analysis – Financial Results
- Spring Valley Acquisition Corp. II (SVIIW) Income Statement Analysis – Financial Results
Medigene AG (MDG1.DE)
About Medigene AG
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.03M | 31.25M | 10.46M | 8.75M | 10.63M | 7.75M | 11.38M | 9.75M | 6.81M | 13.78M | 7.59M | 6.28M | 4.66M | 2.29M | 39.47M | 39.61M | 23.88M | 31.22M |
| Cost of Revenue | 1.64M | 1.98M | 1.36M | 1.29M | 383.00K | 849.00K | 1.62M | 1.40M | 1.10M | 2.09M | 1.74M | 1.25M | 953.00K | 781.00K | 31.48M | 26.93M | -18.49M | -10.67M |
| Gross Profit | 4.39M | 29.26M | 9.10M | 7.46M | 10.25M | 6.91M | 9.75M | 8.35M | 5.71M | 11.70M | 5.86M | 5.03M | 3.70M | 1.51M | 7.98M | 12.68M | 42.37M | 41.89M |
| Gross Profit Ratio | 72.77% | 93.65% | 87.00% | 85.23% | 96.40% | 89.05% | 85.75% | 85.62% | 83.80% | 84.87% | 77.15% | 80.11% | 79.53% | 65.92% | 20.23% | 32.02% | 177.45% | 134.17% |
| Research & Development | 11.55M | 28.50M | 12.80M | 22.26M | 22.62M | 7.21M | 14.88M | 11.54M | 8.53M | 7.50M | 6.61M | 7.40M | 11.25M | 13.49M | 18.50M | 27.47M | -16.94M | -12.34M |
| General & Administrative | 4.29M | 4.99M | 2.82M | 3.62M | 2.73M | 2.75M | 2.58M | 2.47M | 2.27M | 2.29M | 2.54M | 2.79M | 5.83M | 7.37M | 6.93M | -7.72M | 0.00 | 0.00 |
| Selling & Marketing | 20.00K | 80.00K | 116.00K | 653.00K | 260.00K | 434.00K | 1.26M | 2.62M | 899.00K | 762.00K | 806.00K | 859.00K | 2.27M | 2.03M | 2.19M | 2.76M | -916.00K | -753.00K |
| SG&A | 4.30M | 5.07M | 2.94M | 4.27M | 2.99M | 3.19M | 3.84M | 5.09M | 3.17M | 3.06M | 3.34M | 3.65M | 8.10M | 9.40M | 9.12M | -4.96M | -916.00K | -753.00K |
| Other Expenses | 4.70M | 4.42M | 3.35M | 4.26M | 4.80M | 14.15M | 1.93M | 2.44M | 4.45M | 4.03M | 4.19M | -6.17M | 0.00 | 6.21M | -2.42M | -66.30M | 0.00 | 0.00 |
| Operating Expenses | 20.54M | 37.99M | 19.09M | 30.79M | 30.41M | 24.73M | 23.14M | 21.56M | 16.14M | 14.58M | 14.14M | 15.31M | 19.36M | 29.11M | 27.62M | -19.02M | -17.86M | -13.09M |
| Cost & Expenses | 22.18M | 39.97M | 20.45M | 32.08M | 30.79M | 25.58M | 24.76M | 22.97M | 17.25M | 16.67M | 15.87M | 16.56M | 20.31M | 29.89M | 59.11M | 7.91M | -36.35M | -23.76M |
| Interest Income | 135.00K | 29.00K | 19.00K | 63.00K | 158.00K | 220.00K | 274.00K | 305.00K | 62.00K | 27.00K | 24.00K | 55.00K | 131.00K | 26.00K | 129.00K | 1.45M | 2.04M | 0.00 |
| Interest Expense | 548.00K | 659.00K | 364.00K | 428.00K | 450.00K | 146.00K | 1.13M | 1.31M | 2.98M | 1.80M | 1.58M | 1.26M | 0.00 | 1.00K | 5.00K | 2.00K | 47.00K | 0.00 |
| Depreciation & Amortization | 1.46M | 21.85M | 3.43M | 6.47M | 2.37M | 1.57M | 1.27M | 844.00K | 944.00K | 810.00K | 751.00K | 847.00K | 4.68M | 10.06M | 831.00K | 7.12M | 1.36M | 1.07M |
| EBITDA | -14.58M | 13.11M | -6.51M | -21.53M | -17.10M | -19.97M | -10.55M | -7.66M | -9.50M | -3.28M | -7.83M | -12.69M | -10.80M | -17.12M | -21.10M | -26.03M | -29.94M | -6.53M |
| EBITDA Ratio | -241.71% | 42.04% | -62.04% | -245.78% | -160.80% | -197.14% | -92.64% | -121.07% | -139.23% | -23.95% | -94.78% | -237.24% | -216.54% | -746.73% | -53.46% | -65.72% | 157.93% | 79.51% |
| Operating Income | -16.15M | -8.72M | -9.99M | -23.33M | -20.16M | -17.83M | -13.39M | -13.22M | -10.44M | -2.88M | -9.02M | -16.44M | -15.65M | -27.59M | -19.64M | 31.70M | -31.67M | -8.36M |
| Operating Income Ratio | -267.63% | -27.89% | -95.43% | -266.69% | -189.63% | -229.88% | -117.71% | -135.56% | -153.33% | -20.90% | -118.82% | -261.62% | -336.21% | -1,203.93% | -49.76% | 80.04% | -132.63% | -26.77% |
| Total Other Income/Expenses | -443.00K | -647.00K | -298.00K | 261.00K | 243.00K | -3.86M | 237.00K | 3.50M | -2.96M | -3.03M | -1.24M | -4.12M | 180.00K | 417.00K | 3.36M | -1.78M | 322.00K | 8.36M |
| Income Before Tax | -16.59M | -9.37M | -10.28M | -28.40M | -19.92M | -17.00M | -12.94M | -9.72M | -13.40M | -5.91M | -10.26M | -14.80M | -15.47M | -27.18M | -21.94M | -33.15M | 0.00 | 0.00 |
| Income Before Tax Ratio | -274.98% | -30.00% | -98.28% | -324.64% | -187.34% | -219.29% | -113.75% | -99.70% | -196.81% | -42.89% | -135.19% | -235.44% | -332.35% | -1,185.73% | -55.58% | -83.69% | 0.00% | 0.00% |
| Income Tax Expense | -415.00K | -1.04M | -300.00K | 472.00K | 44.00K | 45.00K | 634.00K | -228.00K | -400.00K | -155.00K | 18.00K | 82.00K | -1.24M | -8.89M | 27.00K | -2.36M | 66.23M | 30.65M |
| Net Income | -16.18M | -8.33M | -9.98M | -28.88M | -19.96M | -17.05M | -13.57M | -9.49M | -13.00M | -5.76M | -10.28M | -9.86M | 6.28M | -17.87M | -21.96M | -30.79M | -29.88M | -6.89M |
| Net Income Ratio | -268.10% | -26.66% | -95.41% | -330.04% | -187.75% | -219.87% | -119.32% | -97.36% | -190.94% | -41.77% | -135.43% | -156.89% | 134.90% | -779.62% | -55.65% | -77.74% | -125.12% | -22.07% |
| EPS | -0.66 | -0.34 | -0.41 | -1.18 | -0.81 | -0.72 | -0.63 | -0.48 | -0.77 | -0.47 | -1.07 | -1.06 | 0.68 | -1.95 | -2.57 | -3.62 | -3.79 | -0.96 |
| EPS Diluted | -0.66 | -0.34 | -0.41 | -1.18 | -0.81 | -0.72 | -0.63 | -0.48 | -0.77 | -0.47 | -1.07 | -1.06 | 0.68 | -1.95 | -2.57 | -3.62 | -3.79 | -0.96 |
| Weighted Avg Shares Out | 24.56M | 24.56M | 24.56M | 24.56M | 24.56M | 23.67M | 21.50M | 19.95M | 16.81M | 12.21M | 9.61M | 9.27M | 9.27M | 9.14M | 8.56M | 8.50M | 7.89M | 7.16M |
| Weighted Avg Shares Out (Dil) | 24.56M | 24.56M | 24.56M | 24.56M | 24.56M | 23.67M | 21.50M | 19.95M | 16.81M | 12.21M | 9.63M | 9.34M | 9.30M | 9.18M | 8.56M | 8.50M | 7.89M | 7.16M |
Source: https://incomestatements.info
Category: Stock Reports